Search research articles
Contact Us
Filters
Showing results (11-20 of 34) with videos related to
Page
of 4
Sort By:
Journal of the American Heart Association
|
February 16, 2024
Major Depressive Disorder Impacts Peripheral Artery Disease Risk Through Intermediary Risk Factors
Gabrielle Shakt, Noah L Tsao, Michael G Levin, et al.
Nature Genetics
|
April 15, 2026
Challenges and future directions for Mendelian randomization
Eleanor Sanderson, Michael G Levin, Venexia Walker, et al.
Nature Genetics
|
April 28, 2026
Author Correction: Challenges and future directions for Mendelian randomization
Eleanor Sanderson, Michael G Levin, Venexia Walker, et al.
Open Heart
|
March 25, 2025
Impact of COVID-19 pandemic on rates of congenital heart disease procedures among children: prospective cohort analyses of 26 270 procedures in 17 860 children using CVD-COVID-UK consortium record linkage data
Arun Karthikeyan Suseeladevi, Rachel Denholm, Sonya V Babu-Narayan, et al.
The Lancet Regional Health. Europe
|
July 14, 2022
Effects of general and central adiposity on circulating lipoprotein, lipid, and metabolite levels in UK Biobank: A multivariable Mendelian randomization study
Joshua A Bell, Tom G Richardson, Qin Wang, et al.
Plos Medicine
|
February 22, 2022
Association of COVID-19 vaccines ChAdOx1 and BNT162b2 with major venous, arterial, or thrombocytopenic events: A population-based cohort study of 46 million adults in England
William N Whiteley, Samantha Ip, Jennifer A Cooper, et al.
Vaccine
|
May 21, 2025
Effect of the 2022 COVID-19 booster vaccination campaign in people aged 50 years in England: Regression discontinuity analysis in OpenSAFELY-TPP
Andrea L Schaffer, William J Hulme, Elsie Horne, et al.
Diabetologia
|
July 28, 2022
Evaluating the efficacy and mechanism of metformin targets on reducing Alzheimer's disease risk in the general population: a Mendelian randomisation study
Jie Zheng, Min Xu, Venexia Walker, et al.
Heart (British Cardiac Society)
|
March 11, 2022
Evaluation of antithrombotic use and COVID-19 outcomes in a nationwide atrial fibrillation cohort
Alex Handy, Amitava Banerjee, Angela M Wood, et al.
Nature Communications
|
July 31, 2024
Cohort study of cardiovascular safety of different COVID-19 vaccination doses among 46 million adults in England
Samantha Ip, Teri-Louise North, Fatemeh Torabi, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 34) with videos related to
Sort By:
Page
of 4
Journal of the American Heart Association
|
February 16, 2024
Major Depressive Disorder Impacts Peripheral Artery Disease Risk Through Intermediary Risk Factors
Gabrielle Shakt, Noah L Tsao, Michael G Levin, et al.
Nature Genetics
|
April 15, 2026
Challenges and future directions for Mendelian randomization
Eleanor Sanderson, Michael G Levin, Venexia Walker, et al.
Nature Genetics
|
April 28, 2026
Author Correction: Challenges and future directions for Mendelian randomization
Eleanor Sanderson, Michael G Levin, Venexia Walker, et al.
Open Heart
|
March 25, 2025
Impact of COVID-19 pandemic on rates of congenital heart disease procedures among children: prospective cohort analyses of 26 270 procedures in 17 860 children using CVD-COVID-UK consortium record linkage data
Arun Karthikeyan Suseeladevi, Rachel Denholm, Sonya V Babu-Narayan, et al.
The Lancet Regional Health. Europe
|
July 14, 2022
Effects of general and central adiposity on circulating lipoprotein, lipid, and metabolite levels in UK Biobank: A multivariable Mendelian randomization study
Joshua A Bell, Tom G Richardson, Qin Wang, et al.
Plos Medicine
|
February 22, 2022
Association of COVID-19 vaccines ChAdOx1 and BNT162b2 with major venous, arterial, or thrombocytopenic events: A population-based cohort study of 46 million adults in England
William N Whiteley, Samantha Ip, Jennifer A Cooper, et al.
Vaccine
|
May 21, 2025
Effect of the 2022 COVID-19 booster vaccination campaign in people aged 50 years in England: Regression discontinuity analysis in OpenSAFELY-TPP
Andrea L Schaffer, William J Hulme, Elsie Horne, et al.
Diabetologia
|
July 28, 2022
Evaluating the efficacy and mechanism of metformin targets on reducing Alzheimer's disease risk in the general population: a Mendelian randomisation study
Jie Zheng, Min Xu, Venexia Walker, et al.
Heart (British Cardiac Society)
|
March 11, 2022
Evaluation of antithrombotic use and COVID-19 outcomes in a nationwide atrial fibrillation cohort
Alex Handy, Amitava Banerjee, Angela M Wood, et al.
Nature Communications
|
July 31, 2024
Cohort study of cardiovascular safety of different COVID-19 vaccination doses among 46 million adults in England
Samantha Ip, Teri-Louise North, Fatemeh Torabi, et al.
Page
of 4